keyword
https://read.qxmd.com/read/38635940/uptake-of-risk-reducing-measures-cascade-testing-and-related-challenges-among-carriers-of-breast-cancer-associated-germline-pathogenic-variants-in-mexico
#21
JOURNAL ARTICLE
Fernanda Mesa-Chavez, Yanin Chavarri-Guerra, Dione Aguilar-Y-Mendez, Andrea Becerril-Gaitan, Bryan F Vaca-Cartagena, Araceli Carrillo-Bedoya, Salvador Santiesteban-González, Alejandro Aranda-Gutierrez, Andrés Rodríguez-Faure, Daniela Obregon-Leal, Gregorio Quintero-Beuló, Jose L Rodriguez-Olivares, Melina Miaja, Jeffrey N Weitzel, Cynthia Villarreal-Garza
PURPOSE: Genetic cancer risk assessment (GCRA) provides pathogenic variant (PV) carriers with the invaluable opportunity to undertake timely cancer risk-reducing (RR) measures and initiate cascade testing (CT). This study describes the uptake of these strategies and the related barriers among breast cancer-associated germline PV carriers in Mexico. METHODS: Carriers who were at least 6 months after disclosure of genetic test results at two GCRA referral centers were invited to answer a survey assessing sociodemographic characteristics, awareness of their carrier status and its implications, uptake of RR measures according to international guidelines by PV, CT initiation, and associated challenges...
April 2024: JCO global oncology
https://read.qxmd.com/read/38634484/autophagy-cooperates-with-pdgfra-to-support-oncogenic-growth-signaling
#22
JOURNAL ARTICLE
Joanne E Simpson, Noor Gammoh
Macroautophagy (referred to as autophagy hereafter) is a highly conserved catabolic process which sequesters intracellular substrates for lysosomal degradation. Autophagy-related proteins have been shown to be involved in various aspects of tumor development by engaging with multiple cellular substrates. We recently uncovered a novel role for autophagy in regulating the signaling and levels of PDGFRA, a receptor tyrosine kinase amplified in several cancers. We discovered that PDGFRA can be targeted to autophagic degradation by binding the autophagy cargo receptor SQSTM1...
April 18, 2024: Autophagy
https://read.qxmd.com/read/38631135/molecular-characterization-and-survival-analysis-of-a-cohort-of-glioblastoma-idh-wildtype
#23
JOURNAL ARTICLE
Bilge Dundar, Mouaz Alsawas, Amr Masaadeh, Kyle Conway, Anthony N Snow, Ramakrishna R Sompallae, Aaron D Bossler, Deqin Ma, Osorio Lopes Abath Neto
Glioblastoma, IDH-wild type, the most common malignant primary central nervous system tumor, represents a formidable challenge in clinical management due to its poor prognosis and limited therapeutic responses. With an evolving understanding of its underlying biology, there is an urgent need to identify prognostic molecular groups that can be subject to targeted therapy. This study established a cohort of 124 sequential glioblastomas from a tertiary hospital and aimed to find correlations between molecular features and survival outcomes...
April 5, 2024: Pathology, Research and Practice
https://read.qxmd.com/read/38630910/taurine-inhibits-lung-metastasis-in-triple-negative-breast-cancer-by-modulating-macrophage-polarization-through-pten-pi3k-akt-mtor-pathway
#24
JOURNAL ARTICLE
Yufeng Lin, Yongtong Huang, Yifan Zheng, Wanting Chen, Yongcheng Zhang, Yongxia Yang, Wenbin Huang
Taurine (Tau) has been found to inhibit triple-negative breast cancer (TNBC) invasion and metastasis. However, its effect on tumor-promoting macrophages and tumor suppressor macrophages in breast cancer progression remains unknown. In this study, we investigated the effects of Tau on macrophage polarization and its role in TNBC cell growth, invasion, and metastasis. We induced human THP-1 monocytes to differentiate into M2 macrophages through exogenous addition of interleukin-4. We used the TNBC cell lines MDA-MB-231 and BT-549 cultured in a conditioned medium from M2 macrophages to investigate the effect of Tau on tumor growth and invasion...
April 17, 2024: Journal of Immunotherapy
https://read.qxmd.com/read/38630555/overcoming-osimertinib-resistance-with-akt-inhibition-in-egfrm-driven-non-small-cell-lung-cancer-with-pik3ca-pten-alterations
#25
JOURNAL ARTICLE
Ursula Grazini, Aleksandra Markovets, Lucy Ireland, Daniel O'Neill, Benjamin Phillips, Man Xu, Matthias Pfeifer, Tereza Vaclova, Matthew J Martin, Ludovic Bigot, Luc Friboulet, Ryan Hartmaier, Maria Emanuela Cuomo, Simon T Barry, Paul D Smith, Nicolas Floc'h
PURPOSE: Osimertinib is an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) indicated for the treatment of EGFR mutated (EGFRm)-driven lung adenocarcinomas. Osimertinib significantly improves progression-free survival in first-line treated patients with EGFRm advanced NSCLC. Despite the durable disease control, the majority of patients receiving osimertinib eventually develop disease progression. EXPERIMENTAL DESIGN: ctDNA profiling analysis on-progression plasma samples from patients treated with osimertinib in both first (Phase 3, FLAURA trial) and second-line trials (Phase 3, AURA3 trial) revealed a high prevalence of PIK3CA/AKT/PTEN alterations...
April 17, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38630392/pi3k-akt-mtor-signaling-pathway-an-important-driver-and-therapeutic-target-in-triple-negative-breast-cancer
#26
REVIEW
Huan-Ping Zhang, Rui-Yuan Jiang, Jia-Yu Zhu, Ke-Na Sun, Yuan Huang, Huan-Huan Zhou, Ya-Bing Zheng, Xiao-Jia Wang
Triple-negative breast cancer (TNBC) is a highly heterogeneous tumor lacking estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression. It has higher aggressiveness and metastasis than other subtypes, with limited effective therapeutic strategies, leading to a poor prognosis. The phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mechanistic target of rapamycin (mTOR) signaling pathway is prevalently over-activated in human cancers and contributes to breast cancer (BC) growth, survival, proliferation, and angiogenesis, which could be an interesting therapeutic target...
April 17, 2024: Breast Cancer: the Journal of the Japanese Breast Cancer Society
https://read.qxmd.com/read/38630174/tannic-acid-alleviates-3-nitropropionic-acid-induced-ovarian-damage-in-brandt-s-vole-lasiopodomys-brandtii
#27
JOURNAL ARTICLE
Minghao Yu, Ruiyang Fan, Daochen Wang, Yuxuan Han, Xin Dai, Sheng-Mei Yang
Tannic acid (TA) is a polyphenol with antioxidant properties present in various plants. In this study, we explored the protective effect of TA against ovarian oxidative stress in Brandt's voles and its underlying mechanism. At various doses, 3-nitropropionic acid (3-NPA) was intraperitoneally injected into Brandt's voles to simulate ovarian oxidative stress. Thereafter, various doses of TA were intragastrically administered to examine the protective effect of TA against 3-NPA-induced ovarian damage. Changes in inflammation, autophagy, apoptosis, and oxidative stress-related factors were investigated through various biochemical and histological techniques...
April 17, 2024: Reproductive Sciences
https://read.qxmd.com/read/38629837/the-impact-of-hbx-protein-on-mitochondrial-dynamics-and-associated-signaling-pathways-strongly-depends-on-the-hepatitis-b-virus-genotype
#28
JOURNAL ARTICLE
Anja Schollmeier, Michael Basic, Mirco Glitscher, Eberhard Hildt
Chronic hepatitis B virus (HBV) infections are strongly associated with liver cirrhosis, inflammation, and hepatocellular carcinoma. In this context, the viral HBx protein is considered as a major factor influencing HBV-associated pathogenesis through deregulation of multiple cellular signaling pathways and is therefore a potential target for prognostic and therapeutic applications. However, HBV-associated pathogenesis differs significantly between genotypes, with the relevant factors and in particular the contribution of the genetic diversity of HBx being largely unknown...
April 17, 2024: Journal of Virology
https://read.qxmd.com/read/38627382/therapeutic-role-of-pten-in-tissue-regeneration-for-management-of-neurological-disorders-stem-cell-behaviors-to-an-in-depth-review
#29
REVIEW
Yue Li, Ruishuang Ma, Xia Hao
Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) represents the initial tumor suppressor gene identified to possess phosphatase activity, governing various cellular processes including cell cycle regulation, migration, metabolic pathways, autophagy, oxidative stress response, and cellular senescence. Current evidence suggests that PTEN is critical for stem cell maintenance, self-renewal, migration, lineage commitment, and differentiation. Based on the latest available evidence, we provide a comprehensive overview of the mechanisms by which PTEN regulates activities of different stem cell populations and influences neurological disorders, encompassing autism, stroke, spinal cord injury, traumatic brain injury, Alzheimer's disease and Parkinson's disease...
April 16, 2024: Cell Death & Disease
https://read.qxmd.com/read/38625939/integrated-mutational-landscape-analysis-of-poorly-differentiated-high-grade-neuroendocrine-carcinoma-of-the-uterine-cervix
#30
JOURNAL ARTICLE
Stefania Bellone, Kyungjo Jeong, Mari Kyllesø Halle, Camilla Krakstad, Blair McNamara, Michelle Greenman, Levent Mutlu, Cem Demirkiran, Tobias Max Philipp Hartwich, Yang Yang-Hartwich, Margherita Zipponi, Natalia Buza, Pei Hui, Francesco Raspagliesi, Salvatore Lopez, Biagio Paolini, Massimo Milione, Emanuele Perrone, Giovanni Scambia, Gary Altwerger, Antonella Ravaggi, Eliana Bignotti, Gloria S Huang, Vaagn Andikyan, Mitchell Clark, Elena Ratner, Masoud Azodi, Peter E Schwartz, Charles M Quick, Roberto Angioli, Corrado Terranova, Samir Zaidi, Shuvro Nandi, Ludmil B Alexandrov, Eric R Siegel, Jungmin Choi, Joseph Schlessinger, Alessandro D Santin
High-grade neuroendocrine cervical cancers (NETc) are exceedingly rare, highly aggressive tumors. We analyzed 64 NETc tumor samples by whole-exome sequencing (WES). Human papillomavirus DNA was detected in 65.6% (42/64) of the tumors. Recurrent mutations were identified in PIK3CA, KMT2D/MLL2, K-RAS, ARID1A, NOTCH2, and RPL10. The top mutated genes included RB1, ARID1A, PTEN, KMT2D / MLL2, and WDFY3, a gene not yet implicated in NETc. Somatic CNV analysis identified two copy number gains (3q27.1 and 19q13.12) and five copy number losses (1p36...
April 23, 2024: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/38621914/-bupleuri-radix-paeoniae-radix-alba-medicated-plasma-exerts-effects-on-hepg2-hepatoma-cells-by-regulating-mir-1297-pten-signaling-axis
#31
JOURNAL ARTICLE
Lin Ding, Ruo-Yu Wang, Fan Zhang, Meng-Si Wu, Bin Chen, Ke-Wei Sun
The present study aimed to investigate the effect and mechanism of Bupleuri Radix-Paeoniae Radix Alba medicated plasma on HepG2 hepatoma cells by regulating the microRNA-1297(miR-1297)/phosphatase and tensin homologue deleted on chromosome 10(PTEN) signaling axis. Real-time quantitative PCR(RT-qPCR) was carried out to determine the mRNA levels of miR-1297 and PTEN in different hepatoma cell lines. The dual luciferase reporter assay was employed to verify the targeted interaction between miR-1297 and PTEN. The cell counting kit-8(CCK-8) was used to detect cell proliferation, and the optimal concentration and intervention time of the medicated plasma were determined...
February 2024: Zhongguo Zhong Yao za Zhi, Zhongguo Zhongyao Zazhi, China Journal of Chinese Materia Medica
https://read.qxmd.com/read/38617778/the-role-and-mechanism-of-pdz-binding-kinase-in-hypobaric-and-hypoxic-acute-lung-injury
#32
JOURNAL ARTICLE
Linao Sun, Haoran Yue, Hao Fang, Runze Li, Shicong Li, Jianyao Wang, Pengjie Tu, Fei Meng, Wang Yan, Jinxia Zhang, Elena Bignami, Kyeongman Jeon, Biniam Kidane, Peng Zhang
BACKGROUND: Acute lung injury (ALI) caused by hypobaric hypoxia (HH) is frequently observed in high-altitude areas, and it is one of the leading causes of death in high-altitude-related diseases due to its rapid onset and progression. However, the pathogenesis of HH-related ALI (HHALI) remains unclear, and effective treatment approaches are currently lacking. METHODS: A new mouse model of HHALI developed by our laboratory was used as the study subject (Chinese patent No...
March 29, 2024: Journal of Thoracic Disease
https://read.qxmd.com/read/38617536/bet-inhibition-induces-synthetic-lethality-in-pten-deficient-colorectal-cancers-via-dual-action-on-p21-cip1-waf1
#33
JOURNAL ARTICLE
Guowen Ren, Jinghong Chen, Yue Pu, Eun Ju Yang, Shishi Tao, Pui Kei Mou, Li-Jie Chen, Wenli Zhu, Kin Long Chan, Guanghui Luo, Chuxia Deng, Joong Sup Shim
Loss of PTEN tumor suppressor is an important event during colorectal cancer (CRC) development and is a target for therapeutic exploitation. This study reports that bromodomain and extra-terminal motif (BET) is a synthetic lethal partner of PTEN in CRC. BET inhibition (BETi) selectively induced G1 cell cycle arrest and apoptosis in PTEN-/- CRC. Further, BETi selectively and dose-dependently suppressed the growth of PTEN-/- CRC tumor xenografts in mice and patient-derived organoids. Mechanistically, PTEN-deficient CRC cells elevated the level of cytoplasmic p21CIP1/WAF1 that is hyper-phosphorylated at Thr145 by AKT...
2024: International Journal of Biological Sciences
https://read.qxmd.com/read/38617444/transplantation-of-human-umbilical-cord-blood-mononuclear-cells-promotes-functional-endometrium-reconstruction-via-downregulating-emt-in-damaged-endometrium
#34
JOURNAL ARTICLE
Ruomeng Hu, Ying Wang, Wenwen Li, Hongjiang Liu, Rong Wu, Xuan Xu, Xiaohua Jiang, Qiong Xing, Jianye Wang, Zhaolian Wei
INTRODUCTION: Cell transplantation is an emerging and effective therapeutic approach for enhancing uterine adhesions caused by endometrial damage. Currently, human umbilical cord blood mononuclear cells (HUCBMCs) have been extensively for tissue and organ regeneration. However, their application in endometrial repair remains unexplored. Our investigation focuses on the utilization of HUCBMCs for treating endometrial injury. METHODS: The HUCBMCs were isolated from health umbilical cord blood, and co-cultured with the injured endometrial stromal cells and injured endometrial organoids...
December 2024: Regenerative Therapy
https://read.qxmd.com/read/38614530/multiple-and-hereditary-renal-tumors-a-review-for-radiologists
#35
JOURNAL ARTICLE
M Á Corral de la Calle, J Encinas de la Iglesia, G C Fernández Pérez, A Fraino, M Repollés Cobaleda
80% of renal carcinomas (RC) are diagnosed incidentally by imaging. 2-4% of "sporadic" multifocality and 5-8% of hereditary syndromes are accepted, probably with underestimation. Multifocality, young age, familiar history, syndromic data, and certain histologies lead to suspicion of hereditary syndrome. Each tumor must be studied individually, with a multidisciplinary evaluation of the patient. Nephron-sparing therapeutic strategies and a radioprotective diagnostic approach are recommended. Relevant data for the radiologist in major RC hereditary syndromes are presented: von-Hippel-Lindau, Chromosome-3 translocation, BRCA-associated protein-1 mutation, RC associated with succinate dehydrogenase deficiency, PTEN, hereditary papillary RC, Papillary thyroid cancer- Papillary RC, Hereditary leiomyomatosis and RC, Birt-Hogg-Dubé, Tuberous sclerosis complex, Lynch, Xp11...
2024: Radiología
https://read.qxmd.com/read/38612819/therapeutic-advances-and-challenges-for-the-management-of-hpv-associated-oropharyngeal-cancer
#36
REVIEW
Isis de Araújo Ferreira Muniz, Megan Araujo, Jenna Bouassaly, Fatemeh Farshadi, Mai Atique, Khashayar Esfahani, Paulo Rogerio Ferreti Bonan, Michael Hier, Marco Mascarella, Alex Mlynarek, Moulay Alaoui-Jamali, Sabrina Daniela da Silva
The use of conventional chemotherapy in conjunction with targeted and immunotherapy drugs has emerged as an option to limit the severity of side effects in patients diagnosed with head and neck cancer (HNC), particularly oropharyngeal cancer (OPC). OPC prevalence has increased exponentially in the past 30 years due to the prevalence of human papillomavirus (HPV) infection. This study reports a comprehensive review of clinical trials registered in public databases and reported in the literature (PubMed/Medline, Scopus, and ISI web of science databases)...
April 3, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38612726/targeting-group-3-medulloblastoma-by-the-anti-prune-1-and-anti-lsd1-kdm1a-epigenetic-molecules
#37
JOURNAL ARTICLE
Francesca Bibbò, Fatemeh Asadzadeh, Angelo Boccia, Carmen Sorice, Orazio Bianco, Carmen Daniela Saccà, Barbara Majello, Vittoria Donofrio, Delfina Bifano, Lucia De Martino, Lucia Quaglietta, Adriana Cristofano, Eugenio Maria Covelli, Giuseppe Cinalli, Veronica Ferrucci, Pasqualino De Antonellis, Massimo Zollo
Medulloblastoma (MB) is a highly malignant childhood brain tumor. Group 3 MB (Gr3 MB) is considered to have the most metastatic potential, and tailored therapies for Gr3 MB are currently lacking. Gr3 MB is driven by PRUNE-1 amplification or overexpression. In this paper, we found that PRUNE-1 was transcriptionally regulated by lysine demethylase LSD1/KDM1A. This study aimed to investigate the therapeutic potential of inhibiting both PRUNE-1 and LSD1/KDM1A with the selective inhibitors AA7.1 and SP-2577, respectively...
March 31, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38612604/microrna-expression-profiles-in-human-samples-and-cell-lines-revealed-nine-mirnas-associated-with-cisplatin-resistance-in-high-grade-serous-ovarian-cancer
#38
JOURNAL ARTICLE
Marienid Flores-Colón, Mariela Rivera-Serrano, Víctor G Reyes-Burgos, José G Rolón, Josué Pérez-Santiago, María J Marcos-Martínez, Fatima Valiyeva, Pablo E Vivas-Mejía
Metastasis and drug resistance are major contributors to cancer-related fatalities worldwide. In ovarian cancer (OC), a staggering 70% develop resistance to the front-line therapy, cisplatin. Despite proposed mechanisms, the molecular events driving cisplatin resistance remain unclear. Dysregulated microRNAs (miRNAs) play a role in OC initiation, progression, and chemoresistance, yet few studies have compared miRNA expression in OC samples and cell lines. This study aimed to identify key miRNAs involved in the cisplatin resistance of high-grade-serous-ovarian-cancer (HGSOC), the most common gynecological malignancy...
March 28, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38611113/exploring-the-prognostic-significance-of-set-domain-containing-2-setd2-expression-in-advanced-and-castrate-resistant-prostate-cancer
#39
JOURNAL ARTICLE
Yaser Gamallat, Joema Felipe Lima, Sima Seyedi, Qiaowang Li, Jon George Rokne, Reda Alhajj, Sunita Ghosh, Tarek A Bismar
SET-domain containing 2 (SETD2) is a histone methyltransferase and an epigenetic modifier with oncogenic functionality. In the current study, we investigated the potential prognostic role of SETD2 in prostate cancer. A cohort of 202 patients' samples was assembled on tissue microarrays (TMAs) containing incidental, advanced, and castrate-resistant CRPCa cases. Our data showed significant elevated SETD2 expression in advanced and castrate-resistant disease (CRPCa) compared to incidental cases (2.53 ± 0...
April 8, 2024: Cancers
https://read.qxmd.com/read/38611022/the-therapeutic-efficacy-and-mechanism-of-action-of-gnetin-c-a-natural-compound-from-the-melinjo-plant-in-a-preclinical-mouse-model-of-advanced-prostate-cancer
#40
JOURNAL ARTICLE
Gisella Campanelli, Ekniel Francois, Prashanth Parupathi, Lakshmi Sirisha Devarakonda, Ching Yang, Avinash Kumar, Anait S Levenson
The metastasis-associated protein 1/protein kinase B (MTA1/AKT) signaling pathway has been shown to cooperate in promoting prostate tumor growth. Targeted interception strategies by plant-based polyphenols, specifically stilbenes, have shown great promise against MTA1-mediated prostate cancer progression. In this study, we employed a prostate-specific transgenic mouse model with MTA1 overexpression on the background of phosphatase and tensin homolog ( Pten ) null ( R26MTA1 ; Ptenf/f ) and PC3M prostate cancer cells which recapitulate altered molecular pathways in advanced prostate cancer...
March 29, 2024: Cancers
keyword
keyword
17151
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.